Germany
Japan
United Kingdom
China
USD 1,020.00
6 Weeks
Lenti ORF particles, SIRPA (mGFP-tagged) - Human signal-regulatory protein alpha (SIRPA), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Products
USD 2,220.00
3 Weeks
Lenti ORF particles, ERBB2 (mGFP-tagged) - Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SPNS3 (mGFP-tagged)-Human spinster homolog 3 (Drosophila) (SPNS3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, TNFRSF8 (mGFP-tagged)-Human tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, LRRC15 (Myc-DDK-tagged)-Human leucine rich repeat containing 15 (LRRC15), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, DDR1 (Myc-DDK tagged) - Human discoidin domain receptor tyrosine kinase 1 (DDR1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
2 Weeks
Lenti ORF particles, PTPN2 (Myc-DDK-tagged)-Human protein tyrosine phosphatase, non-receptor type 2 (PTPN2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, PVR (mGFP-tagged) - Human poliovirus receptor (PVR), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, SORT1 (Myc-DDK-tagged)-Human sortilin 1 (SORT1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, KLB (Myc-DDK-tagged)-Human klotho beta (KLB), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, DLL4 (Myc-DDK tagged) - Human delta-like 4 (Drosophila) (DLL4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,092.00
2 Weeks
Lenti ORF particles, PVRL2 (mGFP-tagged)-Human poliovirus receptor-related 2 (herpesvirus entry mediator B) (PVRL2), transcript variant delta, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, CD276 (Myc-DDK-tagged)-Human CD276 molecule (CD276), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, TNFRSF8 (Myc-DDK-tagged)-Human tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,236.00
2 Weeks
Lenti ORF particles, KDR (Myc-DDK-tagged)-Human kinase insert domain receptor (a type III receptor tyrosine kinase) (KDR), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,908.00
3 Weeks
Lenti ORF particles, ITGAL (Myc-DDK-tagged)-Human integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) (ITGAL), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, BTN3A1 (Myc-DDK-tagged)-Human butyrophilin, subfamily 3, member A1 (BTN3A1), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, DAG1 (Myc-DDK-tagged)-Human dystroglycan 1 (dystrophin-associated glycoprotein 1) (DAG1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, PVRL2 (Myc-DDK-tagged)-Human poliovirus receptor-related 2 (herpesvirus entry mediator B) (PVRL2), transcript variant alpha, 200ul, >10^7 TU/mL. Note: ORF is codon optimized
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, PMEL (mGFP-tagged) - Human premelanosome protein (PMEL), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, SLC17A5 (mGFP-tagged) - Human solute carrier family 17 (anion/sugar transporter), member 5 (SLC17A5), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, PVR (Myc-DDK tagged) - Human poliovirus receptor (PVR), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, SLC7A11 (Myc-DDK tagged) - Human solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 (SLC7A11), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TMEM163 (Myc-DDK tagged) - Human transmembrane protein 163 (TMEM163), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TMEM163 (mGFP-tagged) - Human transmembrane protein 163 (TMEM163), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, KIR3DL1 (mGFP-tagged) - Human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 (KIR3DL1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CD33 (mGFP-tagged) - Human CD33 molecule (CD33), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ICOS (Myc-DDK tagged) - Human inducible T-cell co-stimulator (ICOS), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC10A1 (Myc-DDK tagged) - Human solute carrier family 10 (sodium/bile acid cotransporter family), member 1 (SLC10A1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, CALCRL (Myc-DDK-tagged)-Human calcitonin receptor-like (CALCRL), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, CALCRL (mGFP-tagged)-Human calcitonin receptor-like (CALCRL), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, DLL4 (Myc-DDK tagged) - Human delta-like 4 (Drosophila) (DLL4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, DLL4 (mGFP-tagged) - Human delta-like 4 (Drosophila) (DLL4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ILDR2 (Myc-DDK tagged) - Human immunoglobulin-like domain containing receptor 2 (ILDR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ILDR2 (mGFP-tagged) - Human immunoglobulin-like domain containing receptor 2 (ILDR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,908.00
6 Weeks
Lenti ORF particles, ATRN (Myc-DDK tagged) - Human attractin (ATRN), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,908.00
6 Weeks
Lenti ORF particles, ATRN (mGFP-tagged) - Human attractin (ATRN), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, FFAR4 (Myc-DDK tagged) - Human omega-3 fatty acid receptor 1 (O3FAR1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CACNA1A (Myc-DDK tagged) - Human calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (CACNA1A), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, CCR8 (Myc-DDK tagged) - Human chemokine (C-C motif) receptor 8 (CCR8), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 2,148.00
3 Weeks
Lenti ORF particles, ABCB1 (Myc-DDK-tagged)-Human ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MUC4 (Myc-DDK-tagged)-Human mucin 4, cell surface associated (MUC4), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MUC4 (mGFP-tagged)-Human mucin 4, cell surface associated (MUC4), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SPNS3 (Myc-DDK-tagged)-Human spinster homolog 3 (Drosophila) (SPNS3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, SPNS3 (mGFP-tagged)-Human spinster homolog 3 (Drosophila) (SPNS3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, SPNS3 (Myc-DDK-tagged)-Human spinster homolog 3 (Drosophila) (SPNS3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, GHR (Myc-DDK-tagged)-Human growth hormone receptor (GHR), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, TNFRSF8 (Myc-DDK-tagged)-Human tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,248.00
3 Weeks
Lenti ORF particles, TSHR (Myc-DDK tagged) - Human thyroid stimulating hormone receptor (TSHR), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, LRRC15 (Myc-DDK-tagged)-Human leucine rich repeat containing 15 (LRRC15), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Active filters
Lentivirus
- Particles
Families
- Transmembrane
Filter by
Target Symbol
- NRG1 (44)
- BDNF (42)
- CD46 (34)
- FGFR1 (32)
- OPRM1 (30)
- ASPH (28)
- DAG1 (28)
- CD1E (26)
- APP (22)
- FGFR2 (22)
- MUC1 (22)
- ST3GAL3 (22)
- ADGRG1 (20)
- ADGRG2 (20)
- AGTR1 (20)
- CHRM2 (20)
- FCAR (20)
- HFE (20)
- LDLRAD4 (20)
- PRNP (20)
- PTGER3 (20)
- CD44 (18)
- CSF2RA (18)
- MOG (18)
- NRP2 (18)
- NTRK2 (18)
- PROM1 (18)
- RTN4 (18)
- SEMA6D (18)
- SLITRK2 (18)
- STRA6 (18)
- TMPRSS4 (18)
- ZFYVE27 (18)
- CDH23 (16)
- CEACAM1 (16)
- CLEC2D (16)
- CLEC7A (16)
- CMTM1 (16)
- CPT1B (16)
- ENTPD1 (16)
- FCGR3A (16)
- FCRLA (16)
- FXYD3 (16)
- GABRA1 (16)
- GDNF (16)
- GRIN1 (16)
- LDLR (16)
- PTCH1 (16)
- PTPRO (16)
- SEZ6L2 (16)
- SIGLEC10 (16)
- SLC11A2 (16)
- TRPC4 (16)
- TRPM3 (16)
- TSPAN4 (16)
- ADAM15 (14)
- ADAM22 (14)
- AGTRAP (14)
- AIFM1 (14)
- ASGR2 (14)
- ATP2A3 (14)
- BAX (14)
- CCR2 (14)
- CD22 (14)
- CD36 (14)
- CD8B (14)
- CNR1 (14)
- FOLH1 (14)
- GLRA2 (14)
- GPR17 (14)
- HHAT (14)
- IGSF1 (14)
- IL1RAP (14)
- IL5RA (14)
- KCNJ1 (14)
- MGAT1 (14)
- P2RX2 (14)
- SEZ6L (14)
- SIGLEC6 (14)
- SLC14A1 (14)
- SLC29A1 (14)
- SLC39A8 (14)
- SLC3A2 (14)
- TNFRSF25 (14)
- TNFSF13 (14)
- TRPV1 (14)
- ABCB5 (12)
- ABCG1 (12)
- ACVR1C (12)
- ADGRG6 (12)
- APLP2 (12)
- ARMC10 (12)
- ASTN2 (12)
- BACE1 (12)
- BSG (12)
- BTN2A2 (12)
- BTNL8 (12)
- CAV1 (12)
- CCR3 (12)
- CD84 (12)
Species
Vectors
Mutants
Mammalian Cell Selection
Pathways
- Metabolic pathways (1411)
- Neuroactive ligand-receptor interaction (1240)
- Cytokine-cytokine receptor interaction (893)
- Olfactory transduction (718)
- Cell adhesion molecules (CAMs) (676)
- Calcium signaling pathway (552)
- Pathways in cancer (477)
- Hematopoietic cell lineage (445)
- MAPK signaling pathway (351)
- Regulation of actin cytoskeleton (287)
- Natural killer cell mediated cytotoxicity (282)
- Jak-STAT signaling pathway (274)
- Alzheimer's disease (268)
- Endocytosis (251)
- Dilated cardiomyopathy (243)
- Leukocyte transendothelial migration (214)
- Axon guidance (210)
- Chemokine signaling pathway (210)
- Hypertrophic cardiomyopathy (HCM) (209)
- ECM-receptor interaction (207)
- Antigen processing and presentation (206)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (205)
- Lysosome (205)
- Huntington's disease (200)
- N-Glycan biosynthesis (192)
- Focal adhesion (191)
- ABC transporters (180)
- Vascular smooth muscle contraction (179)
- Oxidative phosphorylation (174)
- Viral myocarditis (170)
- Melanogenesis (166)
- Parkinson's disease (164)
- Adherens junction (159)
- Colorectal cancer (147)
- Retinol metabolism (144)
- Drug metabolism - cytochrome P450 (140)
- Systemic lupus erythematosus (140)
- Cardiac muscle contraction (135)
- Tight junction (134)
- Wnt signaling pathway (134)
- ErbB signaling pathway (130)
- SNARE interactions in vesicular transport (130)
- Graft-versus-host disease (128)
- Adipocytokine signaling pathway (127)
- Apoptosis (127)
- PPAR signaling pathway (126)
- Purine metabolism (125)
- Autoimmune thyroid disease (124)
- Basal cell carcinoma (124)
- Gap junction (122)
- Glycerophospholipid metabolism (122)
- Neurotrophin signaling pathway (121)
- Glycosphingolipid biosynthesis - lacto and neolacto series (118)
- Metabolism of xenobiotics by cytochrome P450 (116)
- Prostate cancer (113)
- Sphingolipid metabolism (112)
- Toll-like receptor signaling pathway (112)
- O-Glycan biosynthesis (108)
- Amyotrophic lateral sclerosis (ALS) (107)
- Allograft rejection (106)
- Vibrio cholerae infection (104)
- Melanoma (102)
- TGF-beta signaling pathway (102)
- Type I diabetes mellitus (102)
- Androgen and estrogen metabolism (100)
- Drug metabolism - other enzymes (96)
- Taste transduction (96)
- Epithelial cell signaling in Helicobacter pylori infection (95)
- Primary immunodeficiency (94)
- Starch and sucrose metabolism (94)
- T cell receptor signaling pathway (92)
- Pancreatic cancer (90)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (86)
- Complement and coagulation cascades (84)
- GnRH signaling pathway (83)
- Arachidonic acid metabolism (82)
- Hedgehog signaling pathway (82)
- Heparan sulfate biosynthesis (82)
- Asthma (80)
- Fc gamma R-mediated phagocytosis (80)
- Keratan sulfate biosynthesis (80)
- B cell receptor signaling pathway (78)
- Ether lipid metabolism (78)
- Porphyrin and chlorophyll metabolism (78)
- Long-term depression (76)
- Long-term potentiation (74)
- Fatty acid metabolism (72)
- Glycerolipid metabolism (68)
- p53 signaling pathway (66)
- Ascorbate and aldarate metabolism (64)
- Notch signaling pathway (64)
- Renin-angiotensin system (62)
- Glycosphingolipid biosynthesis - globo series (60)
- Linoleic acid metabolism (60)
- Pentose and glucuronate interconversions (60)
- Chondroitin sulfate biosynthesis (58)
- Chronic myeloid leukemia (56)
- Pyrimidine metabolism (56)
- Small cell lung cancer (55)
- Glycosphingolipid biosynthesis - ganglio series (54)
- Tyrosine metabolism (54)
- Fc epsilon RI signaling pathway (52)
- Prion diseases (52)
- Steroid biosynthesis (48)
- Bladder cancer (46)
- Glutathione metabolism (44)
- Progesterone-mediated oocyte maturation (44)
- Biosynthesis of unsaturated fatty acids (42)
- Renal cell carcinoma (40)
- Glioma (38)
- Insulin signaling pathway (38)
- Pathogenic Escherichia coli infection (38)
- Oocyte meiosis (36)
- Riboflavin metabolism (35)
- Type II diabetes mellitus (35)
- Non-small cell lung cancer (34)
- Ubiquitin mediated proteolysis (34)
- Nicotinate and nicotinamide metabolism (33)
- Endometrial cancer (32)
- Primary bile acid biosynthesis (32)
- RIG-I-like receptor signaling pathway (32)
- Galactose metabolism (31)
- Cytosolic DNA-sensing pathway (30)
- Glycosaminoglycan degradation (30)
- Thyroid cancer (24)
- alpha-Linolenic acid metabolism (24)
- VEGF signaling pathway (23)
- Tryptophan metabolism (22)
- Phosphatidylinositol signaling system (20)
- C21-Steroid hormone metabolism (18)
- Caffeine metabolism (18)
- Cyanoamino acid metabolism (18)
- Glycolysis / Gluconeogenesis (18)
- Nitrogen metabolism (18)
- Phenylalanine metabolism (18)
- Selenoamino acid metabolism (18)
- Taurine and hypotaurine metabolism (18)
- Amino sugar and nucleotide sugar metabolism (16)
- Inositol phosphate metabolism (16)
- NOD-like receptor signaling pathway (16)
- beta-Alanine metabolism (16)
- Glycine (14)
- Limonene and pinene degradation (14)
- O-Mannosyl glycan biosynthesis (14)
- serine and threonine metabolism (14)
- Propanoate metabolism (13)
- Acute myeloid leukemia (12)
- Arginine and proline metabolism (12)
- Cell cycle (12)
- Dorso-ventral axis formation (12)
- Histidine metabolism (12)
- Valine (12)
- leucine and isoleucine degradation (12)
- Citrate cycle (TCA cycle) (10)
- Lysine degradation (10)
- Protein export (10)
- Sulfur metabolism (10)
- Pantothenate and CoA biosynthesis (9)
- Pyruvate metabolism (9)
- Base excision repair (8)
- Butanoate metabolism (8)
- Other glycan degradation (8)
- Terpenoid backbone biosynthesis (8)
- Fatty acid elongation in mitochondria (6)
- Maturity onset diabetes of the young (4)
- Ubiquinone and other terpenoid-quinone biosynthesis (4)
- Fatty acid biosynthesis (1)